Skip to content

A medical records based study for pharmacodynamic of intranasal dexmedetomidine sedation in children

Pharmacodynamics Study of intranasal dexmedetomidine sedation for electroencephalography in children: dose-response studies at different ages.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033577
Enrollment
Unknown
Registered
2020-06-06
Start date
2016-10-01
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

Case series:Intranasal dexmedetomidine was given again

Sponsors

Children's Hospital Affiliated Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 16 Years

Inclusion criteria

Inclusion criteria: This is a retrospective study and our study retrospectively analyzed children who underwent electroencephalogram examination in children's hospital affiliated to chongqing medical university from October 2016 to October 2018.

Exclusion criteria

Exclusion criteria: 1. known allergy to dexmedetomidine; 2. recent treatment with a-2 adrenergic receptor agonist; 3. renal or hepatic dysfunction; 4. nasal discharges.

Design outcomes

Primary

MeasureTime frame
heart rate;

Secondary

MeasureTime frame
Oxygen saturation;respiration rate;

Countries

China

Contacts

Public ContactTu Shengfen

Children's Hospital Affiliated Chongqing Medical University

519194496@qq.com+86 13983416114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026